Main Image
 

Carnegie Mellon University's Biotechnology Innovation and Computation Program


The M.S. in Biotechnology Innovation and Computation (MSBIC) is a program within the School of Computer Science at Carnegie Mellon and is offered jointly through the Language Technologies Institute (LTI) and the Lane Center for Computational Biology (LCCB). This program is designed to educate leaders in applying software and computing technologies to create innovative solutions for the biotechnology, pharmaceutical and health care industries. Students learn to plan, design, build and deliver innovative solutions for these industries utilizing data mining, information retrieval, machine learning, machine translation, computational linguistics, and computational biology technologies. As these industries are rapidly evolving, there is a great need for leaders who can envision, design, plan and deliver solutions that integrate emerging technologies into effective business solutions. Read more >

Recent and Upcoming Events

Sepsis - An Unsolved Problem in Diagnostics
Huan Phan - Director, NVS Technologies
September 29, 2011

Opportunities for Information technology in the Pharmaceutical and Life Sciences
John Shon, Director - Johnson & Johnson Pharmaceuticals
September 22, 2011

The discovering, developing and commercializing of innovative therapies for cancer therapy.
Mark Ahn, CEO & President - RXI Pharmaceuticals
September 15, 2011

The application of language technology in a pharmaceutical company
Tom Vu, Roche Pharmaceuticals
September 8, 2011

In silico Target Discover Based on Flexible Pipelining and Meta-Analysis
James Cai, Director - Roche Pharmaceuticals
September 1, 2011